Short Interest in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Grows By 48.6%

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 5,500 shares, a growth of 48.6% from the October 15th total of 3,700 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 12,500 shares, the days-to-cover ratio is presently 0.4 days.

Institutional Trading of STRATA Skin Sciences

An institutional investor recently bought a new position in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV acquired a new position in shares of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 12,000 shares of the medical device company’s stock, valued at approximately $33,000. Azzad Asset Management Inc. ADV owned 0.34% of STRATA Skin Sciences at the end of the most recent quarter. 32.43% of the stock is currently owned by hedge funds and other institutional investors.

STRATA Skin Sciences Stock Performance

Shares of SSKN stock traded down $0.09 on Friday, hitting $3.01. 5,058 shares of the stock traded hands, compared to its average volume of 12,246. The company has a market capitalization of $12.55 million, a PE ratio of -1.13 and a beta of 1.32. The company’s fifty day moving average is $3.01 and its 200 day moving average is $3.24. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.14 and a quick ratio of 0.92. STRATA Skin Sciences has a 1-year low of $2.51 and a 1-year high of $6.96.

STRATA Skin Sciences (NASDAQ:SSKN) last posted its quarterly earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter. STRATA Skin Sciences had a negative return on equity of 67.36% and a negative net margin of 28.72%. The business had revenue of $8.44 million during the quarter. On average, equities research analysts predict that STRATA Skin Sciences will post -1 earnings per share for the current fiscal year.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.